Centene (NYSE:CNC) General Counsel Christopher Koster Sells 47,603 Shares of Stock

Posted by Brenda Bartman on Aug 19th, 2026

Centene Corporation (NYSE:CNC – Get Free Report) General Counsel Christopher Koster sold 47,603 shares of the stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $65.36, for a total value of $3,111,332.08. Following the sale, the general counsel owned 305,354 shares of the company’s stock, valued at $19,957,937.44. This represents a 13.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Centene Price Performance

Shares of CNC traded down $0.56 during mid-day trading on Wednesday, reaching $64.66. The stock had a trading volume of 2,879,830 shares, compared to its average volume of 5,948,013. The business has a fifty day moving average of $64.96 and a 200 day moving average of $52.01. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.15 and a current ratio of 1.15. Centene Corporation has a 12 month low of $28.24 and a 12 month high of $69.36. The firm has a market cap of $31.94 billion, a price-to-earnings ratio of -6.19, a PEG ratio of 0.36 and a beta of 1.08.

Centene (NYSE:CNC – Get Free Report) last issued its earnings results on Monday, July 27th. The company reported $2.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $1.42. Centene had a negative net margin of 2.51% and a positive return on equity of 12.12%. The firm had revenue of $53.58 billion during the quarter, compared to analysts’ expectations of $47.64 billion. During the same quarter last year, the company posted ($0.16) earnings per share. The firm’s revenue was up 9.9% compared to the same quarter last year. Equities analysts predict that Centene Corporation will post 4.89 EPS for the current year.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Barclays reiterated an “overweight” rating and issued a $80.00 price objective (up from $75.00) on shares of Centene in a research note on Wednesday, July 29th. Stifel Nicolaus set a $79.00 price target on shares of Centene in a research note on Monday, August 3rd. TD Cowen reiterated a “hold” rating and set a $65.00 price target (up from $47.00) on shares of Centene in a report on Tuesday, July 14th. Robert W. Baird upped their price target on shares of Centene from $46.00 to $66.00 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Centene in a report on Friday, July 17th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $70.05.

Read Our Latest Report on Centene

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in CNC. MidFirst Bank purchased a new position in Centene during the second quarter worth about $32,000. Fiduciary Financial Advisors acquired a new stake in Centene during the second quarter worth $34,000. DV Equities LLC acquired a new position in Centene during the 4th quarter worth $26,000. Transamerica Financial Advisors LLC bought a new stake in shares of Centene in the second quarter worth about $42,000. Finally, Elevation Wealth Partners LLC boosted its stake in shares of Centene by 564.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 658 shares of the company’s stock worth $42,000 after acquiring an additional 559 shares during the period. Institutional investors and hedge funds own 93.63% of the company’s stock.

Centene Company Profile

(Get Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.